Industry Research Reports

Home > Reports > Chemical & Material > Global Shingles Vaccine Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global Shingles Vaccine Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Industry: Chemical & Material

Published Date: 2025-02-24

Pages: 65 Pages

Report ld: 4216184

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global Shingles Vaccine market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The global Shingles Vaccine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Shingles Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2020-2031.

MARKET SEGMENTATION

By Company

Merck
GlaxoSmithKline

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Zostavax
Shingrix

Segment by Application

Under 50 Years Old
50-60 Years Old
60-70 Years Old
Above 70 Years Old

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Sales and revenue of Shingles Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region.

Chapter 3: Detailed analysis of Shingles Vaccine manufacturers competitive landscape, sales, revenue, price, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Region analysis by company, by customer, by Type, by Application, sales, revenue, and price for each segment,

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Shingles Vaccine revenue, gross margin, and recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Sales channels analysis

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Shingles Vaccine Product Scope

1.2 Shingles Vaccine by Type

1.2.1 Global Shingles Vaccine Sales by Type (2020 & 2024 & 2031)

1.2.2 Zostavax

1.2.3 Shingrix

1.3 Shingles Vaccine by Application

1.3.1 Global Shingles Vaccine Sales Comparison by Application (2020 & 2024 & 2031)

1.3.2 Under 50 Years Old

1.3.3 50-60 Years Old

1.3.4 60-70 Years Old

1.3.5 Above 70 Years Old

1.4 Global Shingles Vaccine Market Estimates and Forecasts (2020-2031)

1.4.1 Global Shingles Vaccine Market Size in Value Growth Rate (2020-2031)

1.4.2 Global Shingles Vaccine Market Size in Volume Growth Rate (2020-2031)

1.4.3 Global Shingles Vaccine Price Trends (2020-2031)

1.5 Assumptions and Limitations

2 Market Size and Prospective by Region

2.1 Global Shingles Vaccine Market Size by Region: 2020 VS 2024 VS 2031

2.2 Global Shingles Vaccine Retrospective Market Scenario by Region (2020-2025)

2.2.1 Global Shingles Vaccine Sales Market Share by Region (2020-2025)

2.2.2 Global Shingles Vaccine Revenue Market Share by Region (2020-2025)

2.3 Global Shingles Vaccine Market Estimates and Forecasts by Region (2026-2031)

2.3.1 Global Shingles Vaccine Sales Estimates and Forecasts by Region (2026-2031)

2.3.2 Global Shingles Vaccine Revenue Forecast by Region (2026-2031)

2.4 Major Region and Emerging Market Analysis

2.4.1 North America Shingles Vaccine Market Size and Prospective (2020-2031)

2.4.2 Europe Shingles Vaccine Market Size and Prospective (2020-2031)

2.4.3 China Shingles Vaccine Market Size and Prospective (2020-2031)

2.4.4 Japan Shingles Vaccine Market Size and Prospective (2020-2031)

3 Global Market Size by Type

3.1 Global Shingles Vaccine Historic Market Review by Type (2020-2025)

3.1.1 Global Shingles Vaccine Sales by Type (2020-2025)

3.1.2 Global Shingles Vaccine Revenue by Type (2020-2025)

3.1.3 Global Shingles Vaccine Price by Type (2020-2025)

3.2 Global Shingles Vaccine Market Estimates and Forecasts by Type (2026-2031)

3.2.1 Global Shingles Vaccine Sales Forecast by Type (2026-2031)

3.2.2 Global Shingles Vaccine Revenue Forecast by Type (2026-2031)

3.2.3 Global Shingles Vaccine Price Forecast by Type (2026-2031)

3.3 Different Types Shingles Vaccine Representative Players

4 Global Market Size by Application

4.1 Global Shingles Vaccine Historic Market Review by Application (2020-2025)

4.1.1 Global Shingles Vaccine Sales by Application (2020-2025)

4.1.2 Global Shingles Vaccine Revenue by Application (2020-2025)

4.1.3 Global Shingles Vaccine Price by Application (2020-2025)

4.2 Global Shingles Vaccine Market Estimates and Forecasts by Application (2026-2031)

4.2.1 Global Shingles Vaccine Sales Forecast by Application (2026-2031)

4.2.2 Global Shingles Vaccine Revenue Forecast by Application (2026-2031)

4.2.3 Global Shingles Vaccine Price Forecast by Application (2026-2031)

4.3 New Sources of Growth in Shingles Vaccine Application

5 Competition Landscape by Players

5.1 Global Shingles Vaccine Sales by Players (2020-2025)

5.2 Global Top Shingles Vaccine Players by Revenue (2020-2025)

5.3 Global Shingles Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Shingles Vaccine as of 2024)

5.4 Global Shingles Vaccine Average Price by Company (2020-2025)

5.5 Global Key Manufacturers of Shingles Vaccine, Manufacturing Sites & Headquarters

5.6 Global Key Manufacturers of Shingles Vaccine, Product Type & Application

5.7 Global Key Manufacturers of Shingles Vaccine, Date of Enter into This Industry

5.8 Manufacturers Mergers & Acquisitions, Expansion Plans

6 Region Analysis

6.1 North America Market: Players, Segments, Downstream and Major Customers

6.1.1 North America Shingles Vaccine Sales by Company

6.1.1.1 North America Shingles Vaccine Sales by Company (2020-2025)

6.1.1.2 North America Shingles Vaccine Revenue by Company (2020-2025)

6.1.2 North America Shingles Vaccine Sales Breakdown by Type (2020-2025)

6.1.3 North America Shingles Vaccine Sales Breakdown by Application (2020-2025)

6.1.4 North America Shingles Vaccine Major Customer

6.1.5 North America Market Trend and Opportunities

6.2 Europe Market: Players, Segments, Downstream and Major Customers

6.2.1 Europe Shingles Vaccine Sales by Company

6.2.1.1 Europe Shingles Vaccine Sales by Company (2020-2025)

6.2.1.2 Europe Shingles Vaccine Revenue by Company (2020-2025)

6.2.2 Europe Shingles Vaccine Sales Breakdown by Type (2020-2025)

6.2.3 Europe Shingles Vaccine Sales Breakdown by Application (2020-2025)

6.2.4 Europe Shingles Vaccine Major Customer

6.2.5 Europe Market Trend and Opportunities

6.3 China Market: Players, Segments, Downstream and Major Customers

6.3.1 China Shingles Vaccine Sales by Company

6.3.1.1 China Shingles Vaccine Sales by Company (2020-2025)

6.3.1.2 China Shingles Vaccine Revenue by Company (2020-2025)

6.3.2 China Shingles Vaccine Sales Breakdown by Type (2020-2025)

6.3.3 China Shingles Vaccine Sales Breakdown by Application (2020-2025)

6.3.4 China Shingles Vaccine Major Customer

6.3.5 China Market Trend and Opportunities

6.4 Japan Market: Players, Segments, Downstream and Major Customers

6.4.1 Japan Shingles Vaccine Sales by Company

6.4.1.1 Japan Shingles Vaccine Sales by Company (2020-2025)

6.4.1.2 Japan Shingles Vaccine Revenue by Company (2020-2025)

6.4.2 Japan Shingles Vaccine Sales Breakdown by Type (2020-2025)

6.4.3 Japan Shingles Vaccine Sales Breakdown by Application (2020-2025)

6.4.4 Japan Shingles Vaccine Major Customer

6.4.5 Japan Market Trend and Opportunities

7 Company Profiles and Key Figures

7.1 Merck

7.1.1 Merck Company Information

7.1.2 Merck Business Overview

7.1.3 Merck Shingles Vaccine Sales, Revenue and Gross Margin (2020-2025)

7.1.4 Merck Shingles Vaccine Products Offered

7.1.5 Merck Recent Development

7.2 GlaxoSmithKline

7.2.1 GlaxoSmithKline Company Information

7.2.2 GlaxoSmithKline Business Overview

7.2.3 GlaxoSmithKline Shingles Vaccine Sales, Revenue and Gross Margin (2020-2025)

7.2.4 GlaxoSmithKline Shingles Vaccine Products Offered

7.2.5 GlaxoSmithKline Recent Development

8 Shingles Vaccine Manufacturing Cost Analysis

8.1 Shingles Vaccine Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Key Suppliers of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.3 Manufacturing Process Analysis of Shingles Vaccine

8.4 Shingles Vaccine Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

9.1 Marketing Channel

9.2 Shingles Vaccine Distributors List

9.3 Shingles Vaccine Customers

10 Shingles Vaccine Market Dynamics

10.1 Shingles Vaccine Industry Trends

10.2 Shingles Vaccine Market Drivers

10.3 Shingles Vaccine Market Challenges

10.4 Shingles Vaccine Market Restraints

11 Research Findings and Conclusion

12 Appendix

12.1 Research Methodology

12.1.1 Methodology/Research Approach

12.1.1.1 Research Programs/Design

12.1.1.2 Market Size Estimation

12.1.1.3 Market Breakdown and Data Triangulation

12.1.2 Data Source

12.1.2.1 Secondary Sources

12.1.2.2 Primary Sources

12.2 Author Details

12.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Shingles Vaccine Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)

Table 2. Global Shingles Vaccine Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)

Table 3. Global Market Shingles Vaccine Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Table 4. Global Shingles Vaccine Sales (K Doses) by Region (2020-2025)

Table 5. Global Shingles Vaccine Sales Market Share by Region (2020-2025)

Table 6. Global Shingles Vaccine Revenue (US$ Million) Market Share by Region (2020-2025)

Table 7. Global Shingles Vaccine Revenue Share by Region (2020-2025)

Table 8. Global Shingles Vaccine Sales (K Doses) Forecast by Region (2026-2031)

Table 9. Global Shingles Vaccine Sales Market Share Forecast by Region (2026-2031)

Table 10. Global Shingles Vaccine Revenue (US$ Million) Forecast by Region (2026-2031)

Table 11. Global Shingles Vaccine Revenue Share Forecast by Region (2026-2031)

Table 12. Global Shingles Vaccine Sales by Type (K Doses) & (2020-2025)

Table 13. Global Shingles Vaccine Sales Share by Type (2020-2025)

Table 14. Global Shingles Vaccine Revenue by Type (US$ Million) & (2020-2025)

Table 15. Global Shingles Vaccine Price by Type (USD/Dose) & (2020-2025)

Table 16. Global Shingles Vaccine Sales by Type (K Doses) & (2026-2031)

Table 17. Global Shingles Vaccine Revenue by Type (US$ Million) & (2026-2031)

Table 18. Global Shingles Vaccine Price by Type (USD/Dose) & (2026-2031)

Table 19. Representative Players of Each Type

Table 20. Global Shingles Vaccine Sales by Application (K Doses) & (2020-2025)

Table 21. Global Shingles Vaccine Sales Share by Application (2020-2025)

Table 22. Global Shingles Vaccine Revenue by Application (US$ Million) & (2020-2025)

Table 23. Global Shingles Vaccine Price by Application (USD/Dose) & (2020-2025)

Table 24. Global Shingles Vaccine Sales by Application (K Doses) & (2026-2031)

Table 25. Global Shingles Vaccine Revenue Market Share by Application (US$ Million) & (2026-2031)

Table 26. Global Shingles Vaccine Price by Application (USD/Dose) & (2026-2031)

Table 27. New Sources of Growth in Shingles Vaccine Application

Table 28. Global Shingles Vaccine Sales by Company (K Doses) & (2020-2025)

Table 29. Global Shingles Vaccine Sales Share by Company (2020-2025)

Table 30. Global Shingles Vaccine Revenue by Company (US$ Million) & (2020-2025)

Table 31. Global Shingles Vaccine Revenue Share by Company (2020-2025)

Table 32. Global Shingles Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Shingles Vaccine as of 2024)

Table 33. Global Market Shingles Vaccine Average Price by Company (USD/Dose) & (2020-2025)

Table 34. Global Key Manufacturers of Shingles Vaccine, Manufacturing Sites & Headquarters

Table 35. Global Key Manufacturers of Shingles Vaccine, Product Type & Application

Table 36. Global Key Manufacturers of Shingles Vaccine, Date of Enter into This Industry

Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 38. North America Shingles Vaccine Sales by Company (2020-2025) & (K Doses)

Table 39. North America Shingles Vaccine Sales Market Share by Company (2020-2025)

Table 40. North America Shingles Vaccine Revenue by Company (2020-2025) & (US$ Million)

Table 41. North America Shingles Vaccine Revenue Market Share by Company (2020-2025)

Table 42. North America Shingles Vaccine Sales by Type (2020-2025) & (K Doses)

Table 43. North America Shingles Vaccine Sales Market Share by Type (2020-2025)

Table 44. North America Shingles Vaccine Sales by Application (2020-2025) & (K Doses)

Table 45. North America Shingles Vaccine Sales Market Share by Application (2020-2025)

Table 46. Europe Shingles Vaccine Sales by Company (2020-2025) & (K Doses)

Table 47. Europe Shingles Vaccine Sales Market Share by Company (2020-2025)

Table 48. Europe Shingles Vaccine Revenue by Company (2020-2025) & (US$ Million)

Table 49. Europe Shingles Vaccine Revenue Market Share by Company (2020-2025)

Table 50. Europe Shingles Vaccine Sales by Type (2020-2025) & (K Doses)

Table 51. Europe Shingles Vaccine Sales Market Share by Type (2020-2025)

Table 52. Europe Shingles Vaccine Sales by Application (2020-2025) & (K Doses)

Table 53. Europe Shingles Vaccine Sales Market Share by Application (2020-2025)

Table 54. China Shingles Vaccine Sales by Company (2020-2025) & (K Doses)

Table 55. China Shingles Vaccine Sales Market Share by Company (2020-2025)

Table 56. China Shingles Vaccine Revenue by Company (2020-2025) & (US$ Million)

Table 57. China Shingles Vaccine Revenue Market Share by Company (2020-2025)

Table 58. China Shingles Vaccine Sales by Type (2020-2025) & (K Doses)

Table 59. China Shingles Vaccine Sales Market Share by Type (2020-2025)

Table 60. China Shingles Vaccine Sales by Application (2020-2025) & (K Doses)

Table 61. China Shingles Vaccine Sales Market Share by Application (2020-2025)

Table 62. Japan Shingles Vaccine Sales by Company (2020-2025) & (K Doses)

Table 63. Japan Shingles Vaccine Sales Market Share by Company (2020-2025)

Table 64. Japan Shingles Vaccine Revenue by Company (2020-2025) & (US$ Million)

Table 65. Japan Shingles Vaccine Revenue Market Share by Company (2020-2025)

Table 66. Japan Shingles Vaccine Sales by Type (2020-2025) & (K Doses)

Table 67. Japan Shingles Vaccine Sales Market Share by Type (2020-2025)

Table 68. Japan Shingles Vaccine Sales by Application (2020-2025) & (K Doses)

Table 69. Japan Shingles Vaccine Sales Market Share by Application (2020-2025)

Table 70. Merck Company Information

Table 71. Merck Description and Business Overview

Table 72. Merck Shingles Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 73. Merck Shingles Vaccine Product

Table 74. Merck Recent Development

Table 75. GlaxoSmithKline Company Information

Table 76. GlaxoSmithKline Description and Business Overview

Table 77. GlaxoSmithKline Shingles Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 78. GlaxoSmithKline Shingles Vaccine Product

Table 79. GlaxoSmithKline Recent Development

Table 80. Production Base and Market Concentration Rate of Raw Material

Table 81. Key Suppliers of Raw Materials

Table 82. Shingles Vaccine Distributors List

Table 83. Shingles Vaccine Customers List

Table 84. Shingles Vaccine Market Trends

Table 85. Shingles Vaccine Market Drivers

Table 86. Shingles Vaccine Market Challenges

Table 87. Shingles Vaccine Market Restraints

Table 88. Research Programs/Design for This Report

Table 89. Key Data Information from Secondary Sources

Table 90. Key Data Information from Primary Sources

List of Figures

Figure 1. Shingles Vaccine Product Picture

Figure 2. Global Shingles Vaccine Sales (US$ Million) by Type (2020 & 2024 & 2031)

Figure 3. Global Shingles Vaccine Sales Market Share by Type in 2024 & 2031

Figure 4. Zostavax Product Picture

Figure 5. Shingrix Product Picture

Figure 6. Global Shingles Vaccine Sales (US$ Million) by Application (2020 & 2024 & 2031)

Figure 7. Global Shingles Vaccine Sales Market Share by Application in 2024 & 2031

Figure 8. Under 50 Years Old Examples

Figure 9. 50-60 Years Old Examples

Figure 10. 60-70 Years Old Examples

Figure 11. Above 70 Years Old Examples

Figure 12. Global Shingles Vaccine Sales, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Shingles Vaccine Sales Growth Rate (2020-2031) & (US$ Million)

Figure 14. Global Shingles Vaccine Sales (K Doses) Growth Rate (2020-2031)

Figure 15. Global Shingles Vaccine Price Trends Growth Rate (2020-2031) & (USD/Dose)

Figure 16. Shingles Vaccine Report Years Considered

Figure 17. Global Market Shingles Vaccine Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Figure 18. Global Shingles Vaccine Revenue Market Share by Region: 2020 VS 2024

Figure 19. North America Shingles Vaccine Revenue (US$ Million) Growth Rate (2020-2031)

Figure 20. North America Shingles Vaccine Sales (K Doses) Growth Rate (2020-2031)

Figure 21. Europe Shingles Vaccine Revenue (US$ Million) Growth Rate (2020-2031)

Figure 22. Europe Shingles Vaccine Sales (K Doses) Growth Rate (2020-2031)

Figure 23. China Shingles Vaccine Revenue (US$ Million) Growth Rate (2020-2031)

Figure 24. China Shingles Vaccine Sales (K Doses) Growth Rate (2020-2031)

Figure 25. Japan Shingles Vaccine Revenue (US$ Million) Growth Rate (2020-2031)

Figure 26. Japan Shingles Vaccine Sales (K Doses) Growth Rate (2020-2031)

Figure 27. Global Shingles Vaccine Revenue Share by Type (2020-2025)

Figure 28. Global Shingles Vaccine Sales Share by Type (2026-2031)

Figure 29. Global Shingles Vaccine Revenue Share by Type (2026-2031)

Figure 30. Global Shingles Vaccine Revenue Share by Application (2020-2025)

Figure 31. Global Shingles Vaccine Revenue Growth Rate by Application in 2020 & 2024

Figure 32. Global Shingles Vaccine Sales Share by Application (2026-2031)

Figure 33. Global Shingles Vaccine Revenue Share by Application (2026-2031)

Figure 34. Global Shingles Vaccine Sales Share by Company (2024)

Figure 35. Global Shingles Vaccine Revenue Share by Company (2024)

Figure 36. Global 5 Largest Shingles Vaccine Players Market Share by Revenue in Shingles Vaccine: 2020 & 2024

Figure 37. Shingles Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 38. Manufacturing Cost Structure of Shingles Vaccine

Figure 39. Manufacturing Process Analysis of Shingles Vaccine

Figure 40. Shingles Vaccine Industrial Chain

Figure 41. Channels of Distribution (Direct Vs Distribution)

Figure 42. Distributors Profiles

Figure 43. Bottom-up and Top-down Approaches for This Report

Figure 44. Data Triangulation

Figure 45. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Shingles Vaccine market? zhanKai

The top companies in the global Shingles Vaccine market are Merck、GlaxoSmithKline.

Related Reports

Shingles Vaccine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Shingles Vaccine was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 118
USD 3950.00
(Single User License)
Global Shingles Vaccine Market Research Report 2026
The global Shingles Vaccine market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-27
Pages: 122
USD 2900.00
(Single User License)
Global Shingles Vaccine Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Shingles Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-26
Pages: 129
USD 4900.00
(Single User License)
Shingles Vaccine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Shingles Vaccine was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 80
USD 3950.00
(Single User License)
Global Shingles Vaccine Market Research Report 2025
The global market for Shingles Vaccine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-24
Pages: 81
USD 2900.00
(Single User License)
Global Shingles Vaccine Market Insights, Forecast to 2030
The global Shingles Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published Date: 2024-04-19
Pages: 72
USD 4900.00
(Single User License)
Shingles Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Shingles Vaccine was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-24
Pages: 85
USD 3950.00
(Single User License)
Global Shingles Vaccine Market Research Report 2024
The global Shingles Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-05
Pages: 84
USD 2900.00
(Single User License)

Shingles Vaccine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Shingles Vaccine was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 118
USD 3950.00 (Single User License)
Global Shingles Vaccine Market Research Report 2026
The global Shingles Vaccine market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-27
Pages: 122
USD 2900.00 (Single User License)
Global Shingles Vaccine Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Shingles Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-26
Pages: 129
USD 4900.00 (Single User License)
Shingles Vaccine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Shingles Vaccine was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 80
USD 3950.00 (Single User License)
Global Shingles Vaccine Market Research Report 2025
The global market for Shingles Vaccine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-24
Pages: 81
USD 2900.00 (Single User License)
Global Shingles Vaccine Market Insights, Forecast to 2030
The global Shingles Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published: 2024-04-19
Pages: 72
USD 4900.00 (Single User License)
Shingles Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Shingles Vaccine was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-24
Pages: 85
USD 3950.00 (Single User License)
Global Shingles Vaccine Market Research Report 2024
The global Shingles Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-05
Pages: 84
USD 2900.00 (Single User License)